Assignee
KRONOS BIO INC
US·9 granted patents·5 pending applications·8 citations·filing 2018–2025
Top patents by PatentIndex Score
14 records- 0191US10842803B2Imidazopyridines Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Nov 24, 2020·3 cites·11 claims
- 0287US11517570B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineKRONOS BIO INC·Filed 2020·Granted Dec 6, 2022·1 cites·22 claims
- 0385US12152037B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·7 claims
- 0484US12263163B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 0584US11155560B2Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activityKRONOS BIO INC·Filed 2019·Granted Oct 26, 2021·1 cites·4 claims
- 0679US11339168B2Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitorsKRONOS BIO INC·Filed 2020·Granted May 24, 2022·1 cites·4 claims
- 0778US2024132506A1Compounds, compositions, and methods for modulating cdk9 activityKRONOS BIO INC·Filed 2023·Application pending·0 cites
- 0875US11845754B2Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activityKRONOS BIO INC·Filed 2021·Granted Dec 19, 2023·0 cites·11 claims
- 0974US2025313566A1CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORSKRONOS BIO INC·Filed 2024·Application pending·0 cites
- 1073US11384082B2Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Jul 12, 2022·1 cites·21 claims
- 1165US12122781B2Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitorsKRONOS BIO INC·Filed 2022·Granted Oct 22, 2024·0 cites·19 claims
- 1258US2025059193A1Polymorphic and salt forms of (1s,3s)-n1-(5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl) cyclopentane-1,3-diamineKRONOS BIO INC·Filed 2022·Application pending·0 cites
- 1353US2025188084A1Compounds and methods for modulating cdk9 activityKRONOS BIO INC·Filed 2021·Application pending·0 cites
- 1449US2026028344A1Crystalline forms of lanraplenib and methods of making and using the sameKRONOS BIO INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →